NEXT GENERATION INVESTMENT BANKING

Members network
Limited Mobile Version
Follow this company and never miss a research update
ORX

Orexo

Research update

Print

Orexo: Zubsolv Rx Data week 6, 2017

According to latest Symphony Health Solutions Rx data, Zubsolv tablets showed a market share of 5.57% (5.61%), 4-week rolling average. The total number of Zubsolv tablets sold week 6 (5) reaching 325,107 (321,704). Zubsolv prescriptions (TRx) recorded a market share of 5.59% (5.59%), 4-week rolling average. Total number of prescriptions reaching 11,659 (11,777) during the week.

The overall market (buprenorphine/naloxone) showed a y/y growth rate of 8.9% (8.9%) (4-week rolling average unit sales). TRx showed a y/y growth rate by 10.7% (10.4%) (4-week rolling average).

Download full report icon-download